English version

Paris, 17 February 2011. The G5, the association of the major French healthcare companies, announced today its extension to include the bioMérieux group, a global leader in the field of in vitro diagnostics. With medicine undergoing a revolution and new perspectives opening up in terms of personalized patient care, the G5 implements a new strategy, and has decided [...]

Paris (France), 25 January 2011 – The association of the five leading French pharmaceutical groups, known as the G5, has announced that, due to exceptional circumstances affecting his company, Dr. Jacques Servier has informed them of his decision to resign as Chairman of the G5 in order to devote his time to defending his company’s interests. [...]